Piet A van den Brandt1, Leo J Schouten2. 1. Maastricht University Medical Centre, GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht, The Netherlands and Maastricht University Medical Centre, CAPHRI-School for Public Health and Primary Care, Department of Epidemiology, Maastricht, The Netherlands PA.vandenBrandt@maastrichtuniversity.nl. 2. Maastricht University Medical Centre, GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht, The Netherlands and.
Abstract
BACKGROUND: Nut intake has been associated with lower mortality, but few studies have investigated causes of death other than cardiovascular disease, and dose-response relationships remain unclear. METHODS: We investigated the relationship of nut (tree nut, peanut) and peanut butter intake with overall and cause-specific mortality. In the Netherlands Cohort Study, 120,852 men and women aged 55-69 years provided information on dietary and lifestyle habits in 1986. Mortality follow-up until 1996 consisted of linkage to Statistics Netherlands. Multivariate case-cohort analyses were based on 8823 deaths and 3202 subcohort members with complete data on nuts and potential confounders. We also conducted meta-analyses of our results with those published from other cohort studies. RESULTS: Total nut intake was related to lower overall and cause-specific mortality (cancer, diabetes, cardiovascular, respiratory, neurodegenerative diseases, other causes) in men and women. When comparing those consuming 0.1-<5, 5-<10 and 10+ g nuts/day with non-consumers, multivariable hazard ratios for total mortality were 0.88, 0.74 and 0.77 [95% confidence interval (CI), 0.66-0.89], respectively (Ptrend = 0.003). Cause-specific hazard ratios comparing 10+ vs 0 g/day varied from 0.56 for neurodegenerative to 0.83 for cardiovascular disease mortality. Restricted cubic splines showed nonlinear dose-response relationships with mortality. Peanuts and tree nuts were inversely related to mortality, whereas peanut butter was not. In meta-analyses, summary hazard ratios for highest vs lowest nut consumption were 0.85 for cancer, and 0.71 for respiratory mortality. CONCLUSIONS: Nut intake was related to lower overall and cause-specific mortality, with evidence for nonlinear dose-response relationships. Peanut butter was not related to mortality.
BACKGROUND:Nut intake has been associated with lower mortality, but few studies have investigated causes of death other than cardiovascular disease, and dose-response relationships remain unclear. METHODS: We investigated the relationship of nut (tree nut, peanut) and peanut butter intake with overall and cause-specific mortality. In the Netherlands Cohort Study, 120,852 men and women aged 55-69 years provided information on dietary and lifestyle habits in 1986. Mortality follow-up until 1996 consisted of linkage to Statistics Netherlands. Multivariate case-cohort analyses were based on 8823 deaths and 3202 subcohort members with complete data on nuts and potential confounders. We also conducted meta-analyses of our results with those published from other cohort studies. RESULTS: Total nut intake was related to lower overall and cause-specific mortality (cancer, diabetes, cardiovascular, respiratory, neurodegenerative diseases, other causes) in men and women. When comparing those consuming 0.1-<5, 5-<10 and 10+ g nuts/day with non-consumers, multivariable hazard ratios for total mortality were 0.88, 0.74 and 0.77 [95% confidence interval (CI), 0.66-0.89], respectively (Ptrend = 0.003). Cause-specific hazard ratios comparing 10+ vs 0 g/day varied from 0.56 for neurodegenerative to 0.83 for cardiovascular disease mortality. Restricted cubic splines showed nonlinear dose-response relationships with mortality. Peanuts and tree nuts were inversely related to mortality, whereas peanut butter was not. In meta-analyses, summary hazard ratios for highest vs lowest nut consumption were 0.85 for cancer, and 0.71 for respiratory mortality. CONCLUSIONS:Nut intake was related to lower overall and cause-specific mortality, with evidence for nonlinear dose-response relationships. Peanut butter was not related to mortality.
Authors: Alexander Medina-Remón; Rosa Casas; Anna Tressserra-Rimbau; Emilio Ros; Miguel A Martínez-González; Montserrat Fitó; Dolores Corella; Jordi Salas-Salvadó; Rosa M Lamuela-Raventos; Ramón Estruch Journal: Br J Clin Pharmacol Date: 2016-05-19 Impact factor: 4.335
Authors: Gang Liu; Marta Guasch-Ferré; Yang Hu; Yanping Li; Frank B Hu; Eric B Rimm; JoAnn E Manson; Kathryn M Rexrode; Qi Sun Journal: Circ Res Date: 2019-03-15 Impact factor: 17.367
Authors: Maryam Hashemian; Gwen Murphy; Arash Etemadi; Sanford M Dawsey; Linda M Liao; Christian C Abnet Journal: Am J Clin Nutr Date: 2017-08-02 Impact factor: 7.045
Authors: Marta Guasch-Ferré; Xiaoran Liu; Vasanti S Malik; Qi Sun; Walter C Willett; JoAnn E Manson; Kathryn M Rexrode; Yanping Li; Frank B Hu; Shilpa N Bhupathiraju Journal: J Am Coll Cardiol Date: 2017-11-14 Impact factor: 27.203
Authors: Amanda M Fretts; Dariush Mozaffarian; David S Siscovick; Irena B King; Barbara McKnight; Bruce M Psaty; Eric B Rimm; Colleen Sitlani; Frank M Sacks; Xiaoling Song; Nona Sotoodehnia; Donna Spiegelman; Rozenn N Lemaitre Journal: J Nutr Date: 2015-12-23 Impact factor: 4.798